According to The Insight Partners’ Latest Study on “Superdisintegrants Market to 2027″ Includes Global Analysis and Forecasts By Type (Synthetic Superdisintegrants, Natural Superdisintegrants, Other Superdisintegrants); Formulation (Tablets, Capsules); Therapeutic Area (Neurological Diseases, Gastrointestinal Diseases, Oncology, Inflammatory Diseases, Infectious Diseases, Cardiovascular Diseases, Other Diseases) and Geography
‘‘Superdisintegrants Market to 2027 – Global Analysis and Forecasts by Type, Formulation, Therapeutic Area, Application’ the global Superdisintegrants market is projected to reach US$ 659.17 Mn in 2027 from US$ 369.56 Mn in 2019. The market is projected to grow with a CAGR of 7.6% from 2020-2027. The report provides trends predominating in the global superdisintegrants market and the factors driving the market and also the factors that act as hindrances.
Download PDF Sample Copy at:
The Superdisintegrants market is highly competitive and fragmented, with a considerable number of players operating in the market. Most of the companies operating in the superdisintegrants market are present across the globe and have wide distribution and sales networks through partnerships or authorized dealers.
Key Companies Outlook:
The most notable market participants in the Superdisintegrants market include JRS PHARMA, COREL PHARMA CHEM, Roquette Frères, Asahi Kasei Corporation, Merck KGaA, Avantor, Inc., and DFE Pharma. are among others holding a significant share of the Superdisintegrants market owing to their product offerings.
Market leaders are involved in organic ways of business expansion such as product launch, which have promoted its growth. For instance, in October 2019, Ashland Inc. launched Plasdone S630 Ultra, excipient solution for improved drug delivery. The newly launched system is designed to optimize tablet formation, hot melt extrusion (HME) in continuous tablet processing. Along with this system, the company also introduced Benecel XR and XRF and Viatel bioresorbable polymers with an aim to consolidate its position in drug delivery and solid dosage forms market.
Well-known small local companies are present in the market to provide products to its customer base. Larger firms are embracing the strategy of acquiring small/ medium firms to intensify and expand its product portfolio and footprint in different geographies. Additionally, companies are also undergoing acquisitions to garner their significance and remain competitive in the market.
Have a Call with Analyst:
Few of the essential vital developments from the industry are mentioned below:
July, 2019: JRS Pharma announced cDMF (Chinese Drug Master File) filings with the National Medical Products Administration. The company took strategic step to launch wide range of its excipient products in China market
May, 2019: The company opens an advanced laboratory in Lithuania with an aim to consolidate its position in Northern Europe market. The new laboratory is expected to conduct research and development activities for innovation of new products in industrial and pharmaceutical markets
August, 2016: The company commissioned new manufacturing facility in Fuji. The newly opened facility is dedicated for manufacturing of pharmaceutical component
In 2019, the Synthetic Superdisintegrants segment accounted for the largest market share in the global Superdisintegrants market by type. Synthetic disintegrants are more effective in lower concentrations as compared to starch; also they incorporate superior intragranularity, such merits of synthetic superdisintegrants are projected to drive the synthetic superdisintegrants segment in the global superdisintegrants market during the forecast period.
Segments – By Formulation:
Superdisintegrants market, based on the formulation, was segmented into tablets and capsule. In 2019, the tablets segment held the largest share of the market. Moreover, the tablets segment is expected to grow at the fastest rate during the coming year. Tablets are the most prescribed solid dosage form for any disease condition hence they are expected to witness significant growth during the forecast period. The other significant factor driving the growth of the market is the adoption of tablets is considerably high as it offers better dosage administration and uniformity.
Buy Report at:
The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Materials.
If you have any queries about this report or if you would like further information, please contact us:
Contact Person: Sameer Joshi